The Japanese National Cancer Center has harnessed generative artificial intelligence to revolutionize clinical trial documentation. Traditional processes spanning over six months and
AI, like a maestro, is transforming how businesses handle mergers and acquisitions (M&A) by identifying and mitigating human-related risks. NayaDaya Analytics employs
Exaone Deep, LG’s cutting-edge AI, debuted at NVIDIA GTC 2025, showcasing its human-like reasoning capabilities. The AI features a sophisticated inference engine